Thompson Craig B.
SEC insider (Form 3/4/5 filer). CIK 0001423419. Director at CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on May 8, 2026. Located in TARRYTOWN, NY.
Companies Thompson Craig B. has filed insider reports for
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL): Director
- REGENERON PHARMACEUTICALS, INC. (REGN): Director
Thompson Craig B.
CIK: 0001423419
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- May 8, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
AwardDirect1.4K shares at avg. $177.62$255K - Jan 2, 2026REGN
REGENERON PHARMACEUTICALS, INC.
AwardDirect155 shares- - May 21, 2025CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
AwardDirect946 shares at avg. $134.98$128K - Jan 2, 2025REGN
REGENERON PHARMACEUTICALS, INC.
AwardDirect166 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 8, 2026 |  CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Award | 1,438 | $177.62 | $255,418 | Direct |
| Jan 2, 2026 |  REGN REGENERON PHARMACEUTICALS, INC. | Award | 155 | - | $0 | Direct |
| May 21, 2025 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Award | 946 | $134.98 | $127,691 | Direct |
| Jan 2, 2025 | REGN REGENERON PHARMACEUTICALS, INC. | Award | 166 | - | $0 | Direct |
1-4 of 4 transactions